Postoperative quadriceps strength of continuous femoral ropivacaine or levobupivacaine: a prospective, randomized double-blind trial after total knee arthroplasty

Trial Profile

Postoperative quadriceps strength of continuous femoral ropivacaine or levobupivacaine: a prospective, randomized double-blind trial after total knee arthroplasty

Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Sep 2013

At a glance

  • Drugs Levobupivacaine (Primary) ; Ropivacaine (Primary)
  • Indications Postoperative pain
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Sep 2013 Status changed from suspended to discontinued as reported by University Hospital Medical Information Network - Japan.
    • 23 Feb 2013 Status changed from not yet recruiting to suspended as reported by University Hospital Medical Information Network - Japan.
    • 27 Oct 2012 Planned initiation date changed from 7 Nov 2012 to 1 Apr 2013 as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top